$Ifosfamide, Epirubicin and Etoposide (IEV) Regimen as Salvage and Mobilization Therapy for Refractory or Early Relapsing Patients with Aggressive Non-Hodgkin's Lymphoma$

Ifosfamide, Epirubicin and Etoposide (IEV) Regimen as Salvage and Mobilization Therapy for Refractory or Early Relapsing Patients with Aggressive Non-Hodgkin's Lymphoma

The prognosis of early relapsing or refractory aggressive non-Hodgkin's lymphoma (NHL) is still poor. Effective salvage therapy should be able to induce high response rate as well as to mobilize hematopoietic precursors. A combination of ifosfamide, epirubicin and etoposide (IEV) was given to 2...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia & lymphoma 2004-08, Vol.45 (8), p.1605-1609
Hauptverfasser:	Pocali, Barbara, De Simone, Mariacarla, Annunziata, Mario, Palmieri, Salvatore, D'Amico, Maria Rosaria, Copia, Carolina, Viola, Assunta, Mele, Giuseppina, Schiavone, Ettore Mariano, Ferrara, Felicetto
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aggressive non-Hodgkin's lymphoma Antineoplastic Combined Chemotherapy Protocols - therapeutic use Autologous stem cell transplantation Disease-Free Survival Epirubicin - therapeutic use Etoposide - therapeutic use Female Hematopoietic Stem Cell Mobilization Hematopoietic Stem Cell Transplantation Humans IEV regimen Ifosfamide - therapeutic use Lymphoma, Large B-Cell, Diffuse - therapy Lymphoma, Non-Hodgkin - therapy Male Middle Aged Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy Remission Induction Salvage Therapy Transplantation, Autologous Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!